IP Library Granted Patent US 11,938,173
Granted Patent B2
US 11,938,173 · App. 15/534,547 · Granted Mar 26, 2024

Use of

Inventors: Ira Herman (Boston, MA); Vincent Ronfard (Keller, TX); Lei Shi (Mansfield, TX)
Assignee: SMITH & NEPHEW, INC.
A61K38/4886A61K9/0014A61K9/06A61K9/7007A61K35/74A61K38/48A61K45/06C12Y304/24003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,938,173
App. No.
15/534,547
Filed
Jun 9, 2017
Granted
Mar 26, 2024
Kind
B2
Art Unit
1638
USPC
424/94.67
Abstract

Provided are methods for repairing a wound or inducing the proliferative phase of a wound comprising administering a composition comprising a protease mixture comprising collagenases and a neutral protease to the wound in an amount effective for repair of wound tissue or for inducing the proliferative phase in the wound.

Claims (11)

1. A method for inducing proliferation of fibroblasts in a wound in vivo to promote repair of the wound, the method comprising administering a composition comprising a protease mixture comprising collagenases and a neutral protease to the wound in an amount effective for inducing the proliferation of fibroblasts in the wound, wherein the protease mixture is obtained from fermenting Clostridium histolyticum and includes collagenase ColG, collagenase ColH, and non-specific neutral protease, wherein the wound is a diabetic foot ulcer, venous leg ulcer, arterial leg ulcer, decubitus ulcer, stasis ulcer, dermal ulcer, pressure ulcer or a peptic ulcer, wherein the wound is one that has been debrided prior to administration of the composition, and wherein the wound is entirely devoid of necrotic tissue prior to administration of the composition.

2. The method of claim 1 , wherein the method further induces angiogenesis.

3. The method of claim 1 , wherein the method further induces epithelialization.

4. The method of claim 1 , wherein the composition is comprised in a wound dressing.

5. The method of claim 4 , wherein the wound dressing is a patch, wrap, or bandage.

6. The method of claim 1 , wherein the composition is comprised in a spray.

7. The method of claim 1 , wherein the composition is a liquid, salve, dissolvable gel-forming film, cream, powder, film, or semi-solid.

8. The method of claim 1 , wherein the composition is sterile.

9. The method of claim 1 , wherein the composition is administered topically and consists of collagenase ColG, collagenase ColH, non-specific neutral protease, and petrolatum.

10. The method of claim 1 , wherein the composition does not include petrolatum.

11. The method of claim 1 , wherein the composition further comprises an antimicrobial agent selected from an antibiotic or an antiseptic.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2017
From: HERMAN, IRA; RONFARD, VINCENT; SHI, LEI
To: SMITH & NEPHEW, INC.
Reel/Frame 043965/0911 →
Continuity (2)
Provisional Application 62091313 · Dec 12, 2014
Related Publication 20170360904A1 · Dec 21, 2017